NorthWest Biotherapeutics Inc (NWBO)

[skitahoe]

Newman,

I'm curious whether the FlaskWorks unit would be certified by all 4 regulators simultaneously, or if they're going after one at a time. In that it's the U.K. where DCVax-L is available under compassionate use, it would figure that the trials of the FlaskWork unit is being conducted there. Hopefully all regulators will respect the work being done, but I don't know that it is certain.

It's my belief that even if only one regulator certified at first it wouldn't take long before the others would concur, it would happen at the same time they approved the vaccine.

Perhaps something else worthy of discussion is inclusion in the SOC. A poster made the point that insurance might not cover DCVax-L until it was considered part of the SOC. I cannot see how a product that improves SOC treatment by a factor of 2, 3, 4, 5 or more wouldn't immediately become part of the SOC, but if people more experienced than me believe this is possible, and that we'd have to fight to make it part of the SOC, I'd like to hear their reasoning.

Gary